Insider Trading activities of Gilead Sciences Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Gilead Sciences Inc since 2005. The reporting company's ticker symbol is GILD. The reporting company's CIK number is 882095.
The total value of stock buying since 2005 is $2,912,783.
The total value of stock sales since 2005 is $2,370,475,543.
The total value of stock option exercises since 2005 is $452,611,818.



Table 2. Detailed insider stock purchases, sales, and option exercises of Gilead Sciences Inc insiders (GILD) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-11-16 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 23.75 1,662,850
2015-11-09 Milligan John F (President and COO) Sale 100,000 107.94 10,793,500
2015-11-09 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-11-05 Washington Robin L (EVP, CFO) Option Ex 6,000 .00 0
2015-11-02 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 108.36 216,712
2015-11-02 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 33.77 67,550
2015-11-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 109.38 1,312,584
2015-11-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 10,000 24.30 242,950
2015-11-02 Washington Robin L (EVP, CFO) Sale 6,250 109.37 683,556
2015-11-02 Martin John C (Chairman and CEO) Sale 150,000 109.30 16,394,700
2015-11-02 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-10-27 Cogan John Francis Sale 15,000 110.00 1,650,000
2015-10-27 Cogan John Francis Option Ex 15,000 20.70 310,575
2015-10-26 Carter Paul Rutherford (EVP Commercial Ops) Sale 1,500 110.06 165,091
2015-10-26 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 1,500 26.99 40,485
2015-10-26 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 110.00 550,000
2015-10-26 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 24.30 121,475
2015-10-26 Cogan John Francis Sale 15,000 110.00 1,650,000
2015-10-26 Cogan John Francis Option Ex 15,000 20.70 310,575
2015-10-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 99.60 6,972,070
2015-10-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 23.68 1,657,460
2015-10-07 Milligan John F (President and COO) Sale 100,000 99.02 9,901,700
2015-10-07 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-10-05 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 100.00 500,000
2015-10-05 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 24.30 121,475
2015-10-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 98.59 197,180
2015-10-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 33.77 67,550
2015-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 7,000 97.78 684,460
2015-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 24.30 121,475
2015-10-01 Martin John C (Chairman and CEO) Sale 150,000 97.55 14,632,650
2015-10-01 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-09-15 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 110.00 550,000
2015-09-15 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 24.30 121,475
2015-09-15 Cogan John Francis (Director) Sale 15,000 110.00 1,650,000
2015-09-15 Cogan John Francis (Director) Option Ex 15,000 20.70 310,575
2015-09-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 110.69 7,748,300
2015-09-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 23.60 1,652,000
2015-09-08 Milligan John F (President and COO) Sale 100,000 103.39 10,338,700
2015-09-08 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-09-02 Washington Robin L (EVP, CFO) Sale 6,250 102.59 641,162
2015-09-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 103.31 1,239,696
2015-09-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 10,000 24.02 240,250
2015-09-01 Martin John C (Chairman and CEO) Sale 150,000 103.14 15,471,300
2015-09-01 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-08-28 Wilson Gayle E Sale 21,000 106.96 2,246,160
2015-08-28 Wilson Gayle E Option Ex 80,000 20.70 1,656,399
2015-08-25 Martin John C (Chairman and CEO) Sale 133,213 105.48 14,051,973
2015-08-17 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 116.04 8,122,520
2015-08-17 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 22.59 1,581,160
2015-08-07 Milligan John F (President and COO) Sale 100,000 114.49 11,448,600
2015-08-07 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-08-03 Carter Paul Rutherford (EVP Commercial Ops) Sale 5,000 119.32 596,600
2015-08-03 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 5,000 26.99 134,950
2015-08-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 17,000 119.25 2,027,250
2015-08-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 15,000 23.75 356,325
2015-08-03 Cogan John Francis Sale 15,000 120.00 1,800,000
2015-08-03 Cogan John Francis Option Ex 15,000 20.70 310,575
2015-08-03 Martin John C (Chairman and CEO) Sale 150,000 119.22 17,882,400
2015-08-03 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-07-31 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,500 .00 0
2015-07-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 66,261 118.22 7,833,507
2015-07-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 21.57 1,510,250
2015-07-07 Milligan John F (President and COO) Sale 100,000 115.14 11,513,500
2015-07-07 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-07-07 Bischofberger Norbert W (EVP, R&D and CSO) Sale 3,739 119.39 446,399
2015-07-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 3,000 118.24 354,729
2015-07-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 3,000 26.99 80,970
2015-07-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 17,000 116.94 1,987,980
2015-07-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 15,000 23.75 356,325
2015-07-01 Martin John C (Chairman and CEO) Sale 150,000 117.00 17,549,700
2015-07-01 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-06-26 Cogan John Francis Sale 27,000 120.13 3,243,429
2015-06-26 Cogan John Francis Option Ex 27,000 17.52 473,121
2015-06-18 Carter Paul Rutherford (EVP Commercial Ops) Sale 10,000 120.00 1,200,030
2015-06-18 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 10,000 26.99 269,900
2015-06-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 117.48 8,223,810
2015-06-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 21.57 1,510,250
2015-06-08 Milligan John F (President and COO) Sale 100,000 114.34 11,434,100
2015-06-08 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-06-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 3,000 113.09 339,279
2015-06-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 3,000 33.77 101,325
2015-06-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 17,000 113.79 1,934,464
2015-06-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 15,000 23.68 355,170
2015-06-01 Martin John C (Chairman and CEO) Sale 150,000 113.77 17,065,050
2015-06-01 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-05-15 Carter Paul Rutherford (EVP Commercial Ops) Sale 6,000 110.00 660,018
2015-05-15 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 6,000 60.60 363,630
2015-05-15 Alton Gregg H (EVP, Corp & Med Affairs) Sale 25,000 110.01 2,750,200
2015-05-15 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 25,000 21.34 533,575
2015-05-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 109.38 7,656,810
2015-05-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 21.16 1,481,060
2015-05-10 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 5,000 .00 0
2015-05-07 Milligan John F (President and COO) Sale 100,000 101.12 10,111,800
2015-05-07 Milligan John F (President and COO) Option Ex 100,000 14.50 1,450,300
2015-05-05 Whitley Richard James Option Ex 23,624 9.81 231,869
2015-05-05 Cogan John Francis Option Ex 1,904 .00 0
2015-05-05 Wilson Gayle E Option Ex 1,904 .00 0
2015-05-05 Davignon Etienne Option Ex 1,904 .00 0
2015-05-05 Hills Carla A Option Ex 1,904 .00 0
2015-05-05 Wold Olsen Per Option Ex 1,904 .00 0
2015-05-05 Madigan John W Option Ex 1,904 .00 0
2015-05-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 103.18 206,366
2015-05-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 80.65 161,300
2015-05-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 104.77 1,257,240
2015-05-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 10,000 19.09 190,850
2015-05-01 Washington Robin L (EVP, CFO) Sale 16,842 104.77 1,764,452
2015-05-01 Washington Robin L (EVP, CFO) Option Ex 16,842 32.43 546,152
2015-05-01 Martin John C (Chairman and CEO) Sale 150,000 104.66 15,699,000
2015-05-01 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-04-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 103.52 7,246,050
2015-04-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 20.74 1,451,800
2015-04-08 Carter Paul Rutherford (EVP Commercial Ops) Sale 1,000 100.00 100,000
2015-04-08 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 1,000 80.65 80,650
2015-04-08 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 100.00 500,000
2015-04-08 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 19.09 95,425
2015-04-01 Carter Paul Rutherford (EVP Commercial Ops) Sale 1,000 98.04 98,044
2015-04-01 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 1,000 80.65 80,650
2015-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 7,000 96.70 676,872
2015-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 19.09 95,425
2015-04-01 Martin John C (Chairman and CEO) Sale 150,000 97.12 14,568,750
2015-04-01 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-03-16 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 100.77 7,053,830
2015-03-16 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 18.57 1,299,760
2015-03-02 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 104.18 208,364
2015-03-02 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 80.65 161,300
2015-03-02 Whitley Richard James Sale 5,000 103.43 517,135
2015-03-02 Whitley Richard James Option Ex 5,000 26.99 134,950
2015-03-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 103.82 1,245,840
2015-03-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 10,000 19.09 190,850
2015-03-02 Martin John C (Chairman and CEO) Sale 150,000 103.51 15,526,200
2015-03-02 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-03-01 Moore Nicholas G Option Ex 167 .00 0
2015-02-17 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 102.96 7,207,130
2015-02-17 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 16.39 1,147,650
2015-02-06 Wold Olsen Per Buy 10,000 99.92 999,150
2015-02-02 Carter Paul Rutherford (EVP Commercial Ops) Sale 2,000 106.16 212,310
2015-02-02 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 2,000 80.65 161,300
2015-02-02 Whitley Richard James Sale 5,000 106.01 530,030
2015-02-02 Whitley Richard James Option Ex 5,000 26.99 134,950
2015-02-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 12,000 105.98 1,271,808
2015-02-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 10,000 19.09 190,850
2015-02-02 Washington Robin L (EVP, CFO) Sale 33,192 105.99 3,518,020
2015-02-02 Washington Robin L (EVP, CFO) Option Ex 33,192 26.92 893,661
2015-02-02 Martin John C (Chairman and CEO) Sale 150,000 105.98 15,896,550
2015-02-02 Martin John C (Chairman and CEO) Option Ex 150,000 14.50 2,175,450
2015-01-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 70,000 98.73 6,911,380
2015-01-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 70,000 16.39 1,147,650
2015-01-08 Carter Paul Rutherford (EVP Commercial Ops) Sale 1,000 100.88 100,881
2015-01-08 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 1,000 33.77 33,775
2015-01-08 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 100.89 504,450

Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences Inc (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.